We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sino Biological Logo

Sino Biological

Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones.

Latest Sino Biological Content

Tfh Cells and Associated Cytokines: The B Cell Modulators content piece image
Product
Advertisement

Tfh Cells and Associated Cytokines: The B Cell Modulators

The T follicular helper (Tfh) cells are a specialized subset of CD4+ T cells essential for the survival, affinity maturation, and class switch recombination of B cells. They promote effective B-cell antibody-mediated immune responses. Dysregulation of Tfh cells is linked to autoimmune disorder systemic sclerosis and chronic graft-versus-host-disease.
IFN-γ: A Key Player in Cancer Immunity content piece image
Product
Advertisement

IFN-γ: A Key Player in Cancer Immunity

Sino Biological has developed a panel of recombinant IFN-γ protein and receptors reagents to support the study of IFN-γ in cancer immunity.
High-Quality Cytokines for T Cell Culture content piece image
Product
Advertisement

High-Quality Cytokines for T Cell Culture

T cell-mediated therapies, such as CAR-T or tumor-infiltrating lymphocytes therapies, hold promise to transform cancer treatment to be more personalized and effective. Cytokines have a fundamental role in T cell survival, expansion, and differentiation.
Type I IFNs: First-Line of Defense Against Viral Infections and Neoplastic Transformation content piece image
Product
Advertisement

Type I IFNs: First-Line of Defense Against Viral Infections and Neoplastic Transformation

Sino Biological has developed an array of high-quality Proteins, Antibodies, Genes, Lysate, and qPCR Primer Pairs to support the study of IFN-Is.
Recombinant Monkeypox Virus Antigens content piece image
Product
Advertisement

Recombinant Monkeypox Virus Antigens

Sino Biological has developed recombinant MPXV A29 and L1R proteins, and A33R, A35R, and B21R Proteins are coming soon.
Therapeutic Targets in CAR NK-Cell Therapy content piece image
Product
Advertisement

Therapeutic Targets in CAR NK-Cell Therapy

Natural killer (NK) cells are immune cells capable of killing target cells and can be genetically modified to express chimeric antigen receptors (CARs). CAR NK-cell therapy is an innovative type of cancer immunotherapy for solid tumors and hematological malignancies.
Therapeutic Targets for Neurodegenerative Diseases content piece image
Product
Advertisement

Therapeutic Targets for Neurodegenerative Diseases

Sino Biological has developed a panel of high-quality recombinant GDNF, NGF, and BDNF to support the research for neurodegenerative diseases.
Sino Biological and Ainnocence Partner To Offer Next-Generation Antibody Development CRO Services content piece image
Product News

Sino Biological and Ainnocence Partner To Offer Next-Generation Antibody Development CRO Services

Sino Biological, Inc. is pleased to announce a CRO services partnership with Ainnocence, Inc. of San Jose, California.
IL-18: A Pleiotropic Pro-Inflammatory Cytokine content piece image
Product
Advertisement

IL-18: A Pleiotropic Pro-Inflammatory Cytokine

Interleukin-18 (IL-18) is a pleiotropic pro-inflammatory cytokine. It belongs to the IL-1 superfamily and participates in innate and acquired immunity. Recent studies have implicated the IL-18 pathway in autoimmune diseases, metabolic disorders, and cancers.IL-21: A Modulator in Allergy, Cancer, and Viral Infections
GDNF: A Neurotrophic and Neuroprotective Factor content piece image
Product
Advertisement

GDNF: A Neurotrophic and Neuroprotective Factor

Glial cell line-derived neurotrophic factor (GDNF) plays a vital role in promoting motor neuron survival and axon outgrowth. It is being evaluated in clinical trials as a potential therapeutic for Parkinson’s disease. GFL-like drugs are also being developed to treat disorders such as neuropathic pain and addiction.
Advertisement